Parathyroid hormone-eluting bead - CellMedAlternative Names: CellBead-PTH; PTH-eluting bead
Latest Information Update: 10 Aug 2007
At a glance
- Originator CellMed
- Class Calcium regulators; Osteoporosis therapies; Peptide hormones
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypoparathyroidism
Most Recent Events
- 10 Aug 2007 Discontinued - Phase-II for Hypoparathyroidism in Germany (Intralesional)
- 15 Nov 2005 Phase-II clinical trials in Hypoparathyroidism in Germany (Intralesional)